Aim: To examine whether a novel endothelin receptor antagonist, CPU0213, is effective in relieving the acute renal failure (ARF) of septic shock by suppressing the activated endothelin-reactive oxygen species (ET-ROS) pathway and nuclear factor kappa B (NF-κB). Methods: The cecum was ligated and punctured in rats under anesthesia. CPU0213 (30 mg·kg -1 ·d -1 , bid, sc×3 d) was administered 8 h after surgical operation. Results: In the untreated septic shock group, the mean arterial pressure and survival rate were markedly decreased (P<0.01), and heart rate, weight index of kidney, serum creatinine and blood urea nitrogen, 24 h urinary protein and creatinine were significantly increased (P<0.01). The levels of ET-1, total NO synthetase (tNOS), indusible nitric oxide synthetase (iNOS), nitric oxide (NO), and ROS in serum and the renal cortex were markedly increased (P< 0.01). The upregulation of the mRNA levels of preproET-1, endothelin converting enzyme, ET A , ET B , iNOS, and tumor necrosis factor-alpha in the renal cortex was significant (P<0.01). The protein amount of activated NF-κB was significantly increased (P<0.01) in comparison with the sham operation group. All of these changes were significantly reversed after CPU0213 administration. Conclusion: Upregulation of the ET signaling pathway and NF-κB play an important role in the ARF of septic shock. Amelioration of renal lesions was achieved by suppressing the ET A and ET B receptors in the renal cortex following CPU0213 medication.
Introduction
An acute renal failure (ARF) that is frequently involved in septic shock is a major medical concerns because of its high morbidity and mortality [1] . Severe infection of Gramnegative bacteria in the peritoneal cavity occurs frequently or endotoxin participates in sepsis, which is implicated with the dysfunction of multi-organs. A higher mortality was reported in septic shock patients with ARF than in those whose renal failure was not predominant. Continuous efforts are being made to discover new drugs for treating ARF and to clarify the underlying mechanisms [2] . Endothelin-1 (ET-1) is released from the normal and diseased renal tissue [3] and exaggerates renal insult in animal models [4] . The findings from clinical investigations show that plasma levels of ET-1 are present in patients with endstage renal insufficiency and high levels of ET-1 correlated with the extent of renal dysfunction in sepsis [5] . So it is of interest to investigate an altered ET-signaling pathway in the renal insult from septic shock. An enhancement of the ET-1 signaling pathway exists in septic shock, and the first endothelin receptor antagonist, bosentan, retrieves the abnormalities in the cardiovascular system [6, 7] . A novel endothelin receptor antagonist, CPU0213, was discovered by screening newly synthetic compounds in our laboratory. The potency to block the ET A and ET B receptors tested by radio receptor binding in IC 50 is 2.57±1.41 and 95±34 nmol/L, respectively. The pA 2 assessed by functional suppression on the activity mediated by the ET A and ET B is 8.52±0.26 and 7.28±0.04, respectively, and is more potent than that of bosentan [8, 9] . It is effective in combating pulmonary hypertension, and relieving acute and chronic cardiac failure in rats. The plasma half-life of CPU0213 is not long enough (within 2 h), but the effectiveness has been proved using one daily oral dose [8] [9] [10] . The aim of the present study was to test the efficacy of CPU0213, which blocks both the ET A and ET B receptors when treating ARF in septic shock rats. There has always been controversy over whether the ET A receptor only or both the ET A and ET B receptors are activated in certain pathological progression. The nuclear factor kappa B (NF-κB) is an important factor in regulating the transcription process and is likely implicated in the renal insult of septic shock mediated by an activated ET pathway. It is hypothesized that an activated ET signaling pathway in which both the ET A and ET B receptors are activated plays a critical pathological role in promoting the acute renal dysfunction in septic shock. The upregulation of mRNA levels of the ET signaling pathway are possibly modulated by an activated NF-κB and renal abnormalities in septic shock could be attenuated following the application of the novel endothelin receptor antagonist CPU0213. CPU0213 was used to treat rats with septic shock caused by acute diffuse peritonitis due to a leakage of feces from the cecal ligation and puncture (CLP). The ability of CPU0213 to attenuate the abnormalities of ARF are possibly mediated by suppressing an activated ET pathway and upregulated NF-κB.
Materials and methods
Animals, drug and experimental protocols Fifty-four male adult Wistar rats (250-280 g, Animal Center of Nanjing Medical University) received a standard diet and free water. The treatment of the animals adhered to the guidelines of the Heath Science Center of Nanjing (Jiangsu). The animals were allowed to readjust to the new housing environment for 1 week before the experiments. CPU0213 (Figure 1 ) was provided from the Center of New Drug Research of China Pharmaceutical University.
Septic shock was induced in the rats by CLP procedures according to the published literature [11] . Eight hours after surgery, the operated rats were divided randomly into 2 groups: the untreated septic shock group and CPU0213 (30 mg·kg -1 ·d -1 ×3 d, bid, sc) treated group. The same volume of normal saline was injected sc in the sham operation and untreated septic shock group.
Measurement of urinary protein and creatinine The 24-h urine collection of each rat was acidified with 0.1 mol/L HCl, separated by centrifugation, and the supernatant was collected and stored at -70 o C before analysis. The urinary protein and creatinine were determined by a spectrophotometric method with kits (Nanjing Jiancheng Bio-engineering Company, Nanjing, China).
Survival rate, hemodynamics and samples prepared The survival rate of rats was monitored within 72 h following surgical operation. At 72 h after operating, the rats were anesthetized with urethane, and a polyethylene catheter (PE 50 , ID 0.58 mm, OD 0.965 mm, Becton Dickinson, San Jose, CA, USA) connected to a pressure transducer (MPA-V, Second Military Medical University, Shanghai, China) was inserted into the right common carotid. The mean arterial pressure (MAP) and heart rate (HR) were monitored using a lead II ECG. Thereafter, blood samples were withdrawn and the animals were killed. Collected blood samples were divided into two portions, one was mixed with EDTA to separate plasma, and the other was centrifuged directly to separate serum. Two kidneys were immediately taken out, decapsulated and weighed, and then the renal cortex was separated from the kidneys. A part of the renal cortex (50 mg/rat) was boiled in 1 mL 0.1% acetic acid for 10 min and then the homogenates and the supernatant were collected for ET-1 assay. A portion of renal cortex (100 mg/rat) was homogenized in normal saline and the supernatant was collected for biochemical measurements. The samples of renal cortex, plasma, serum and homogenates were stored at -70 o C before use.
Measurement of biochemistry in plasma, serum and renal cortex Plasma and renal cortex concentrations of ET-1 were determined by a radioimmunoassay method following the instructions on the radioimmunoassay kit (Beijing Northern Bioengineering Institute, Beijing, China). The serum creatinine, blood urea nitrogen, and serum and renal cortex levels of total nitric oxide synthase ( tNOS ), inducible NOS (iNOS), NO, xanthine oxidase (XOD), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-P X ) and malondialdehyde (MDA) were determined by spectrophotometric method with kits (Nanjing Jiancheng Bio-engineering Company).
mRNA expressions of the renal cortex by RT-PCR The The amplification products were separated by agarose gel electrophoresis (1.7%), stained with ethidium-bromide, and the bands were analyzed by Labworks imaging acquisition and analysis software (Ultra-Violet Products, Cambridge, UK).
Western blot analysis The renal cortex (approximately 100 mg), which had been snap frozen in liquid nitrogen, was homogenized in lysis buffer (50 mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl, 0.02% Sodium Azide, 0.1% SDS, PMSF 100 mg/mL, Aprotinin 1 mg/mL 1% NP-40, 0.5% sodium deoxycholate) using a tissue homogenizer. The lysate was analyzed for protein content using a Bradford assay (Bio-Rad, Hercules, CA, USA). Equal amounts of protein were resolved under reducing conditions on an 8% SDS-polyacrylamide gel. Immunoblotting was performed using a monoclonal antibody that specifically recognizes the IκB-binding region on the p65 subunit to detect activated NF-κB (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1:100 in non-fat milk : Tris buffer. The membrane was subsequently probed with a secondary anti-goat antibody conjugated to horseradish peroxidase (Santa Cruz Biotechnology) at a dilution of 1:1000 and detected with 0.1% 3,3'-diaminobenzidine/0.01% hydrogen peroxide. The bands were analyzed by Labworks imaging acquisition and analysis software (Cambridge, UK).
Statistical analysis Data were expressed as mean±SD. The one way ANOVA assay was performed and differences between two groups were compared by the StudentNewman-Keuls (SNK) test. The results were considered significant at P<0.05.
Results
Survival rate, MAP and HR The survival time and rate of the untreated septic shock group were 38.2±3.3 h and 9.1% (P<0.01) against zero deaths found in the sham operation group. A marked fall in MAP (-36.9%) and an increased HR (30.7%) were found in the CLP group, which showed a sustained hypotensive status due to septic shock. The treatment of CPU0213, which was instituted 8 h after the diffused infection of peritoneal cavity by the feces leakage from the punctured cecum, prolonged the survival time and rate by 53.6±4.0 h and 35.2%. It was significantly effective to raise the MAP and reduce the HR rather than untreated group (P<0.01) (Figure 2 , Table 1 ).
Serum creatinine, blood urea nitrogen, urinary protein, creatinine and the renal weight index Serum creatinine and blood urea nitrogen levels increased by 202.8% and 92.9%, respectively (P<0.01) in the untreated septic shock group. After administration of CPU0213, the elevated serum creatinine and blood urea nitrogen decreased significantly (P< 0.01) in contrast to the untreated group ( Table 2) .
The total urinary protein and creatinine levels in urine in Table 2) . The weight index of the kidney (renal weight/body weight; g/100 g) increased by 8.5% (P<0.01) in the untreated septic shock group, 0.77±0.02 versus the sham operation group 0.71±0.03; and a regression by treatment with CPU0213 was noticed down to 0.73±0.02, P<0.01 in comparison to the untreated septic shock group. The bodyweight (g) among three groups showed no changes: sham operation group, 263.9±11.5; untreated septic shock group, 257.3±12.7; and CPU0213 group, 260.9±10.1.
Activated ET pathway Plasma and renal cortex ET-1 concentrations increased significantly by 142.8% and 49.6% (P<0.01) in the untreated septic shock group, and the mRNA expression levels of ECE, preproET-1, ET A and ET B receptors were significantly upregulated in the renal cortex tissue of the septic kidney, with an increase in abundance of mRNA by 41.3%, 82.1%, 155.6%, and 143.5%, respectively (P<0.01) in contrast to the sham operation group. This indicated that an activated ET pathway was prominent in the renal cortex in the presence of septic shock. The application of CPU0213 led to dramatic regression in upregulation of the renal ET system. An elevated ET-1 in the plasma and renal cortex were significantly suppressed against the untreated group (P<0.01) and toward the control, respectively. CPU0213 was capable of reducing the upregulated mRNA expressions of the ECE, PreproET-1, ET A and ET B receptors toward the control (P<0.01) in contrast to the untreated septic shock group ( Figure 3A−3C) .
Oxidative status in serum and renal cortex The changes in the redox system significantly showed a status of oxidative stress in septic shock rats following CLP. In the untreated septic shock group, the XOD and MDA levels increased by 68.6% and 53.8% in serum and by 52.8% and 225.6% in the renal cortex, (P<0.01), respectively. Decreases in CAT, GSH-P X and SOD levels of -80.9%, -50.8% and -19.6% in the serum and -57.1%, -28.6%, and -19.9% in the renal cortex, respectively, were found in contrast to the sham operation group (P<0.01). CPU0213 significantly ameliorated the impaired redox system by reducing the altered parameters toward the normal (P<0.01) versus the untreated, respectively (Tables 3, 4) .
NOS in the serum and renal cortex The activity of tNOS, iNOS and NO levels in serum and renal cortex were, in the untreated septic shock group, significantly increased by 63.6%, 175.8%, and 125.4% in serum, and 83.8%, 208.0%, and 134.7% in the renal cortex (P<0.01), respectively. The mRNA levels of iNOS in renal cortex of the untreated group were significantly upregulated by 78.1% (P<0.01) versus the sham operation group. CPU0213 significantly attenuated the abnormal activity of tNOS, iNOS and NO in both serum and renal cortex (P<0.01), versus the untreated septic shock group, respectively. A decline in the mRNA expression of the iNOS in the renal cortex was also achieved by CPU0213 ( Figure 4A−4D) .
TNF-α and NF-κB in the renal cortex In the untreated Figure 2 . The survival rate in septic shock was found at 72 h following a surgically ligated and punctured cecum (sham operation group: n=15; untreated septic shock group: n=22; CPU0213 group: n=17). (Figure 5 A) . The relative protein amount of activated NF-κB in renal cortex of the untreated septic shock group increased significantly by 110.0% (P<0.01) versus the sham operation group, and reduced dramatically by CPU0213 (P<0.01) versus the untreated group ( Figure 5B ).
Discussion
The septic shock model of rats was well established by manifestations of a sustained hypotension, an increased HR and a high mortality in the untreated septic shock group following the CLP. The acute compromised renal function was manifested by an increment in serum creatinine, blood urea nitrogen, 24-h urinary protein and creatinine. The excessive proteinuria was sourced from an increase in the permeability of the damaged glomerular membrane and the renal tubular cell injury in septic kidney. The significant increase of the serum and urinary creatinine reflected the development of ARF. A renal insult from inflammatory reaction in the kidney was also manifested by an increment in the renal weight index in the untreated septic shock group. These pathological changes in the kidney were attributed to the maladaptive hemodynamics and the excessive activated cytokines: TNF-α [17] , iNOS [18] , free radicals [19] and excessive ET-1 released in septic shock.
ET-1 is expressed in the glomerular and tubular cells and combination with an upregulation of the mRNA of preproET-1 and ECE provide an over-activity of the ET system, which is implicated in toxic insult to the renal glomerular filtration and tubular function. An over-activated ET system was also manifested by an upregulation of both the ET A and ET B receptors, indicating that there is a co-contribution of the ET A and the ET B receptors to the renal abnormalities in response to septic shock. The findings of the ET B receptors involved in the septic kidney is in keeping with the facts that the ET B constricts blood vessels in pathological conditions and the suppression of the activated ET B in breast cancer provides more efficacies to paclitaxel [21] , and both the ET A and ET B are involved in the failing rat heart. So an activation of the ET B takes an active part in the insult to the kidney in septic shock and the benefit is likely sourced from the dual blockade of the ET A and ET B by CPU0213.
An increase in the blood pressure in the response to CPU0213 improves the renal perfusion to bring about regression of the abnormality. An endothelin receptor antagonist had been proved to be more beneficial against the angiotensin receptor type 1 (AT1) blocker to improve ischemia-induced acute renal failure and a comparison was made between bosentan and losartan [22] . Furthermore, a combination of losartan with bosentan did not produce a relief comparable to bosentan alone because of a hypotensive response that is harmful to the diseased kidney developed by the AT1 blocking effect.
A considerable number of recent studies suggest that oxidant stress plays a major role in the progression of ARF [23] . When the endogenous antioxidant reserve is compromised the renal glomeruli and tubules are predisposed to damage following an oxidative stress episode. Under stimulation by the ROS, an excessive release of ET-1 is anticipated and the ROS is actually a component of the down-stream events of the activated ET signaling pathway [24] . An increase in ROS production is also subsequent to exaggerated ET-1 production [25] . Suppression on the ET receptors is followed by substantial inhibition on ROS production leading to a dramatic attenuation in the balance between the enzymatic activities of the redox system. The activation of the ET receptors induces an exacerbated iNOS mRNA expression and activity. A copious amount of NO, which is produced from an activated iNOS, belongs to the non-physiological component as a consequence to inflammatory reaction of the septic shock [15] . An increased non-physiological NO offers an opportunity to form a toxic peroxynitrite ONOO· -, which exaggerates the status of oxidative stress in the renal tissue. An activation of the iNOS contributes significantly to the deleterious effects of endotoxin in producing hypotension, an excess of ET-1 is released from the mesangial cells in response to ischemia and toxic insult [3] . The renal cortex produces the ET-1, which is critically related to renal injury [20] . The half-life of the released ET-1 is as short as 15 min and an elevated plasma ET-1, which is more than that in the renal tissue, is sourced and multiplied by continuous and profound biosynthesis and release from other organs, such as the heart, vasculature, and lungs, which are attacked in septic shock. In the renal cortex, an increased ET-1 level in Figure 5 . An upregulation of mRNA expression of TNF-α and protein expression of activated NF-κB in renal cortex was found in septic shock rats by CLP, and suppressed by CPU0213 (30 mg·kg renal injury and dysfunction and cardiac depression [16] [17] [18] . Free radicals stimulating cytokine expression and formation promote apoptotic cell death in the failing renal cells [21] . These abnormalities can be subsided dramatically by a dual endothelin receptor antagonist, CPU0213.
The transcription processes in the nucleus are accelerated under the septic conditions, which result from several mechanisms. An excessive ROS can stimulate the transcription in the nuclear to upregulate the mRNA abundance of the ET system and iNOS, in accordance with previously published reports [5, 22] . The NF-κB, a post-transcription regulating factor, is retained in cytoplasm as an inactivated form in quiescent cells in association with its inhibitor, the inhibitory κB (IκB), which masks the nuclear localization sequence of NF-κB. In septic shock, in response to bacterial endotoxin and ROS, the IκB is phosphorylated by IκB kinase (IKK) and detached from NF-κB allowing NF-κB to translocate into the nucleus where it binds to target genes to promote transcription. The TNF-α is actively implicated in acute renal failure by endotoxemia [26] . There is an interaction among the TNF-α, NF-κB, and ET system [27] . It is indicated that an interlink between the ET-1, NF-κB and TNF-α is tight [28] and an enhanced ET-signaling pathway frequently activates the NF-κB, which in turn upregulates transcription and posttranscription of bioactive substances in the presence of the enhanced ET pathway. This occurs in renal insult by septic shock. Activation of the ET system and upregulation of NF-κB and TNF-α are also closely linked with ROS in the pathological progression involving the MAPK pathway [29] . Recovery of upregulation of NF-κB protein and TNF-α, preproET-1 and ECE mRNA are achieved following the ET A and ET B blockade by CPU0213, consequently ameliorating the ARF in septic shock. Remarkably, even the medication was delayed as long as 8 h after septic infection, the effect was still significant. It indicated that CPU0213 was potent to attenuate the abnormalities in ARF in septic shock.
In conclusion, the upregulated ET A and ET B receptors are involved in the activated ET system, which is linked with upregulated NF-κB, TNF-α, iNOS and oxidative stress in the pathological process of ARF in septic shock. The application of an endothelin receptor antagonist, CPU0213, is effective and rational due to its dual blockage of the two upregulated ET A and ET B receptors.
